Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Immuneering Corporation | IMRX | $4.82 | $311.84M | — | |
| Semler Scientific, Inc. | SMLR | $20.33 Jan 21, 2026 | $311.11M | 3.9 | — |
| TriSalus Life Sciences, Inc. | TLSI | $5.00 | $307.87M | — | |
| Orchestra BioMed Holdings, Inc. | OBIO | $5.08 | $305.33M | — | |
| Myriad Genetics, Inc. | MYGN | $3.19 | $305.12M | — | |
| Bicycle Therapeutics plc | BCYC | $4.30 | $300.97M | — | |
| CapsoVision, Inc. | CV | $5.99 | $299.78M | — | |
| Turn Therapeutics Inc. | TTRX | $9.80 | $297.60M | — | |
| Fate Therapeutics, Inc. | FATE | $2.48 | $297.15M | — | |
| Fulcrum Therapeutics, Inc. | FULC | $3.85 | $293.74M | — | |
| Foghorn Therapeutics Inc. | FHTX | $4.92 | $292.18M | — | |
| ProQR Therapeutics N.V. | PRQR | $2.07 | $292.12M | — | |
| Amarin Corporation plc | AMRN | $13.63 | $287.90M | — | |
| Anbio Biotechnology | NNNN | $6.54 | $287.05M | 43.6 | — |
| AC Immune SA | ACIU | $2.86 | $284.36M | — | |
| Cartesian Therapeutics, Inc. | RNAC | $9.27 | $280.47M | — | |
| MacroGenics, Inc. | MGNX | $4.40 | $280.28M | — | |
| Anika Therapeutics, Inc. | ANIK | $20.81 | $278.50M | — | |
| ALX Oncology Holdings Inc. | ALXO | $2.01 | $277.94M | — | |
| So-Young International Inc. | SY | $2.76 | $277.70M | — | |
| Entrada Therapeutics, Inc. | TRDA | $7.13 | $277.62M | — | |
| CAMP4 THERAPEUTICS CORPORATION | CAMP | $4.41 | $276.74M | — | |
| Biodesix, Inc. | BDSX | $26.18 | $276.23M | — | |
| Alector, Inc. | ALEC | $2.46 | $274.68M | — | |
| Lineage Cell Therapeutics, Inc. | LCTX | $1.08 | $273.14M | — | |
| Healwell AI Inc. | AIDX.TO | CA$0.81 | CA$270.82M | — | |
| Akebia Therapeutics, Inc. | AKBA | $0.98 | $270.10M | — | |
| Standard BioTools Inc. | LAB | $0.69 | $269.11M | — | |
| Surrozen, Inc. | SRZN | $22.76 | $267.51M | — | |
| RxSight, Inc. | RXST | $6.38 | $265.16M | — | |
| Anavex Life Sciences Corp. | AVXL | $2.86 | $265.11M | — | |
| Satellos Bioscience Inc. | MSCL.TO | CA$12.45 | CA$264.14M | — | |
| Whitehawk Therapeutics, Inc. | WHWK | $4.60 | $262.24M | — | |
| Cardiol Therapeutics Inc. | CRDL | $2.20 | $257.01M | — | |
| YD Bio Ltd | YDES | $3.54 | $250.74M | — | — |
| NervGen Pharma Corp. | NGEN | $2.33 | $250.53M | — | |
| Aurora Cannabis Inc. | ACB | $3.95 | $250.07M | — | |
| Medical Facilities Corporation | DR.TO | CA$15.42 | CA$250.00M | 12.1 | 2.33% |
| Veraxa Biotech AG | VRXA | $1.76 | $248.88M | — | |
| Neumora Therapeutics, Inc. | NMRA | $1.31 | $246.14M | — | |
| Eledon Pharmaceuticals, Inc. | ELDN | $3.02 | $245.41M | — | |
| Compugen Ltd. | CGEN | $2.59 | $245.34M | 6.8 | — |
| InfuSystem Holdings, Inc. | INFU | $12.24 | $243.79M | 30.6 | — |
| Invivyd, Inc. | IVVD | $0.83 | $243.47M | — | |
| Atrium Therapeutics, Inc. | RNA | $14.19 | $242.73M | — | |
| Adagene Inc. | ADAG | $3.58 | $240.37M | — | |
| OraSure Technologies, Inc. | OSUR | $3.48 | $240.01M | — | |
| SIGA Technologies, Inc. | SIGA | $3.29 | $236.39M | — | |
| Pro-Dex, Inc. | PDEX | $73.41 | $235.16M | 15.0 | — |
| Electromed, Inc. | ELMD | $28.00 | $234.25M | 21.5 | — |
Immuneering Corporation
Healthcare / Biotechnology
- Market Cap
- $311.84M
- P/E
- unprofitable
Semler Scientific, Inc.
Healthcare / Medical Devices
- Market Cap
- $311.11M
- P/E
- 3.9
TriSalus Life Sciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $307.87M
- P/E
- unprofitable
Orchestra BioMed Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $305.33M
- P/E
- unprofitable
Myriad Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $305.12M
- P/E
- unprofitable
Bicycle Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $300.97M
- P/E
- unprofitable
CapsoVision, Inc.
Healthcare / Medical Devices
- Market Cap
- $299.78M
- P/E
- unprofitable
Turn Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $297.60M
- P/E
- unprofitable
Fate Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $297.15M
- P/E
- unprofitable
Fulcrum Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $293.74M
- P/E
- unprofitable
Foghorn Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $292.18M
- P/E
- unprofitable
ProQR Therapeutics N.V.
Healthcare / Biotechnology
- Market Cap
- $292.12M
- P/E
- unprofitable
Amarin Corporation plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $287.90M
- P/E
- unprofitable
Anbio Biotechnology
Healthcare / Medical Instruments & Supplies
- Market Cap
- $287.05M
- P/E
- 43.6
AC Immune SA
Healthcare / Biotechnology
- Market Cap
- $284.36M
- P/E
- unprofitable
Cartesian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $280.47M
- P/E
- unprofitable
MacroGenics, Inc.
Healthcare / Biotechnology
- Market Cap
- $280.28M
- P/E
- unprofitable
Anika Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $278.50M
- P/E
- unprofitable
ALX Oncology Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $277.94M
- P/E
- unprofitable
So-Young International Inc.
Healthcare / Health Information Services
- Market Cap
- $277.70M
- P/E
- unprofitable
Entrada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $277.62M
- P/E
- unprofitable
CAMP4 THERAPEUTICS CORPORATION
Healthcare / Biotechnology
- Market Cap
- $276.74M
- P/E
- unprofitable
Biodesix, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $276.23M
- P/E
- unprofitable
Alector, Inc.
Healthcare / Biotechnology
- Market Cap
- $274.68M
- P/E
- unprofitable
Lineage Cell Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $273.14M
- P/E
- unprofitable
Healwell AI Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$270.82M
- P/E
- unprofitable
Akebia Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $270.10M
- P/E
- unprofitable
Standard BioTools Inc.
Healthcare / Medical Devices
- Market Cap
- $269.11M
- P/E
- unprofitable
Surrozen, Inc.
Healthcare / Biotechnology
- Market Cap
- $267.51M
- P/E
- unprofitable
RxSight, Inc.
Healthcare / Medical Devices
- Market Cap
- $265.16M
- P/E
- unprofitable
Anavex Life Sciences Corp.
Healthcare / Biotechnology
- Market Cap
- $265.11M
- P/E
- unprofitable
Satellos Bioscience Inc.
Healthcare / Biotechnology
- Market Cap
- CA$264.14M
- P/E
- unprofitable
Whitehawk Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $262.24M
- P/E
- unprofitable
Cardiol Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $257.01M
- P/E
- unprofitable
YD Bio Ltd
Healthcare / Biotechnology
- Market Cap
- $250.74M
NervGen Pharma Corp.
Healthcare / Biotechnology
- Market Cap
- $250.53M
- P/E
- unprofitable
Aurora Cannabis Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $250.07M
- P/E
- unprofitable
Medical Facilities Corporation
Healthcare / Medical Care Facilities
- Market Cap
- CA$250.00M
- P/E
- 12.1
- Dividend Yield
- 2.33%
Veraxa Biotech AG
Healthcare / Biotechnology
- Market Cap
- $248.88M
- P/E
- unprofitable
Neumora Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $246.14M
- P/E
- unprofitable
Eledon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $245.41M
- P/E
- unprofitable
Compugen Ltd.
Healthcare / Biotechnology
- Market Cap
- $245.34M
- P/E
- 6.8
InfuSystem Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $243.79M
- P/E
- 30.6
Invivyd, Inc.
Healthcare / Biotechnology
- Market Cap
- $243.47M
- P/E
- unprofitable
Atrium Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $242.73M
- P/E
- unprofitable
Adagene Inc.
Healthcare / Biotechnology
- Market Cap
- $240.37M
- P/E
- unprofitable
OraSure Technologies, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $240.01M
- P/E
- unprofitable
SIGA Technologies, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $236.39M
- P/E
- unprofitable
Pro-Dex, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $235.16M
- P/E
- 15.0
Electromed, Inc.
Healthcare / Medical Devices
- Market Cap
- $234.25M
- P/E
- 21.5
Showing 601–650 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.